Meropenem Fresenius Kabi 500 mg inj./inf. sol. (pwdr.) i.v. vial

Pajjiż: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredjent attiv:

Meropenem Trihydrate 570 mg - Eq. Meropenem 500 mg

Disponibbli minn:

Fresenius Kabi SA-NV

Kodiċi ATC:

J01DH02

INN (Isem Internazzjonali):

Meropenem Trihydrate

Dożaġġ:

500 mg

Għamla farmaċewtika:

Powder for solution for injection/infusion

Kompożizzjoni:

Meropenem Trihydrate 570 mg

Rotta amministrattiva:

Intravenous use

Żona terapewtika:

Meropenem

Sommarju tal-prodott:

CTI code: 374087-01 - Pack size: 500 mg - Commercialisation status: NO - CNK code: 2834091 - Delivery mode: Medical prescription; CTI code: 374096-02 - Pack size: 10 x 500 mg - Commercialisation status: NO - CNK code: 2825420 - Delivery mode: Medical prescription; CTI code: 374096-01 - Pack size: 500 mg - Commercialisation status: NO - CNK code: 2834059 - Delivery mode: Medical prescription; CTI code: 374087-02 - Pack size: 10 x 500 mg - Commercialisation status: YES - FMD code: 05425025650767 - CNK code: 2825420 - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: Yes

Data ta 'l-awtorizzazzjoni:

2010-07-27